Inaccurate MDS Assessment for Anticoagulant Use
Summary
The facility failed to accurately complete a Minimum Data Set (MDS) assessment for a resident, identified as Resident #4, who was readmitted to the facility from the hospital with a diagnosis of coronary artery disease. The MDS assessment, completed on September 13, 2024, incorrectly documented that the resident took an anticoagulant medication during the 7-day look-back period. However, the resident's Care Plan indicated that anticoagulant therapy was resolved and removed from the Care Plan on April 30, 2023. The Order Summary showed that the resident's anticoagulant medication, Eliquis (Apixaban), was discontinued on July 9, 2024, and the Medication Administration Record (MAR) confirmed this discontinuation. During an interview, the MDS Coordinator, identified as Staff C, reported that she gathered information from the resident's record, interviews with the resident and family, and her own observations while providing care. Staff C confirmed that Resident #4 no longer took Apixaban, as it was discontinued on July 9, 2024. The RAI Manual Version 3.0 specifies that MDS assessment section N0410E should only be marked when a resident took an anticoagulant during the 7-day look-back period, excluding antiplatelet medications like aspirin. The inaccurate completion of the MDS assessment for Resident #4 represents a deficiency in ensuring accurate resident assessments.
Penalty
Resources
Below are regulatory guidelines relevant to this citation:
Trusted data from CMS and state health departments
Every citation, penalty and Plan of Correction is sourced from public CMS records (latest release August 26, 2026) and official state health department websites — never guesswork.
In your survey window? See what surveyors are citing.
The Survey-Prep Report maps your facility's risk from 12 months of CMS and state citation data — what's being cited around you and what to check first. $129 one-time.